Murphy Keith — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 17, 2026
Murphy Keith is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
Keith Murphy is the Executive Chairman of VivoSim Labs, Inc. (VIVS) as disclosed in the latest SEC filing dated January 30, 2026, with no reported securities purchases or sales. VivoSim Labs, Inc. is described as the entity formerly known as Organovo Holdings, Inc., a biotechnology company focused on FXR314 in inflammatory bowel disease and related liver toxicology screening. The SEC context indicates his governance and strategic oversight role with the company.
Role
Insider
Notability
25/100
Board memberships
VivoSim Labs, Inc. (VIVS)
Organovo Holdings Inc. (former identity)
Awards & honors
Executive Chairman role at VivoSim Labs, guiding governance and strategy
Led involvement in a company transitioning identity from Organovo Holdings Inc. to VivoSim Labs
Listed as an insider in SEC filings with no reported purchases or sales
Keith Murphy is the Executive Chairman of VivoSim Labs, Inc. (VIVS) as disclosed in the latest SEC filing dated January 30, 2026, with no reported securities purchases or sales. VivoSim Labs, Inc. is described as the entity formerly known as Organovo Holdings, Inc., a biotechnology company focused on FXR314 in inflammatory bowel disease and related liver toxicology screening. T…
Where can I see all of Murphy Keith's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
